Literature DB >> 8492339

Acute digitalis intoxication--is pacing still appropriate?

P Taboulet1, F J Baud, C Bismuth, E Vicaut.   

Abstract

Over a six year period, 92 patients intoxicated with either digitoxin or digoxin were admitted to our ICU. Fifty-one patients were treated with cardiac pacing and/or Fab fragments, and the mortality rate was 13% (14 were intoxications with digoxin, 36 with digitoxin, 1 was mixed). Forty-five cases were suicide attempts; six were accidental overdosages. Since cardiac pacing may trigger fatal arrhythmia or delay the administration of Fab fragments, we conducted a retrospective study to determine whether fatal outcomes could be related either to cardiac pacing or to unsatisfactory use of immunotherapy. In our study, prevention of life-threatening arrhythmia failed in 8% of cases with Fab and in 23% with pacing. Though Fab tended to be more effective, this difference was not significant. In our study, the main obstacles to the success of Fab were pacing-induced arrhythmias and delayed or insufficient administration of Fab. Iatrogenic accidents of cardiac pacing were frequent (14/39, 36%) and often fatal (5/39, 13%). In contrast, immunotherapy was not associated with any serious adverse effects (0/28, 0%) and was safer than cardiac pacing (p < 0.05). In conclusion, during digitalis intoxication, the pacemaker has limited preventive and curative effects, is difficult to handle, and exposes patients to severe iatrogenic accidents. Fab fragments act as a powerful antidote and are safer and much easier to use than pacing. These results encourage us to prescribe Fab fragments as first-line therapy during acute digitalis intoxication.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492339     DOI: 10.3109/15563659309000393

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  11 in total

Review 1.  Pharmacological treatment of cardiac glycoside poisoning.

Authors:  Darren M Roberts; Gamini Gallapatthy; Asunga Dunuwille; Betty S Chan
Journal:  Br J Clin Pharmacol       Date:  2015-12-15       Impact factor: 4.335

Review 2.  Successful treatment of oleander intoxication (cardiac glycosides) with digoxin-specific Fab antibody fragments in a 7-year-old child: case report and review of literature.

Authors:  C Camphausen; N A Haas; A C Mattke
Journal:  Z Kardiol       Date:  2005-12

Review 3.  Advances in the management of digoxin toxicity in the older patient.

Authors:  S W Borron; C Bismuth; J Muszynski
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

4.  Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.

Authors:  Frédéric Lapostolle; Stephen W Borron; Carine Verdier; Fabrice Arnaud; James Couvreur; Bruno Mégarbane; Frédéric Baud; Frédéric Adnet
Journal:  Intensive Care Med       Date:  2008-04-04       Impact factor: 17.440

5.  Cutaneous absorption of Oleander: Fact or fiction.

Authors:  S Senthilkumaran; S Saravanakumar; P Thirumalaikolundusubramanian
Journal:  J Emerg Trauma Shock       Date:  2009-01

6.  Diurnal variation in probability of death following self-poisoning in Sri Lanka--evidence for chronotoxicity in humans.

Authors:  Robert Carroll; Chris Metcalfe; David Gunnell; Fahim Mohamed; Michael Eddleston
Journal:  Int J Epidemiol       Date:  2012-11-23       Impact factor: 7.196

Review 7.  Antidotes for acute cardenolide (cardiac glycoside) poisoning.

Authors:  D M Roberts; N A Buckley
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 8.  Utility of the electrocardiogram in drug overdose and poisoning: theoretical considerations and clinical implications.

Authors:  Christopher Yates; Alex F Manini
Journal:  Curr Cardiol Rev       Date:  2012-05

9.  Toxic bradycardias in the critically ill poisoned patient.

Authors:  Melissa L Givens
Journal:  Emerg Med Int       Date:  2012-04-01       Impact factor: 1.112

Review 10.  Acute plant poisoning and antitoxin antibodies.

Authors:  Michael Eddleston; Hans Persson
Journal:  J Toxicol Clin Toxicol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.